Print Page     Close Window     

SEC Filings

6-K
AC IMMUNE SA filed this Form 6-K on 08/09/2017
Entire Document
 
 

 

Statements of Changes in Equity

 

  Note  Share
capital
  Share
premium
  Accumulated losses  Total
in CHF thousands     
Balance as of January 1, 2016     928    110,496    (40,381)   71,043 
Net income for the period     -    -    6,774    6,774 
Other comprehensive (loss)     -    -    (368)   (368)
Total comprehensive income     -    -    6,406    6,406 
                       
Share-based payments     -    -    150    150 
Issuance of shares:                      
preferred Series E extension shares     28    13,178    -    13,206 
exercise of options     32    199    -    231 
Transaction costs     -    (494)   -    (494)
Balance as of June 30, 2016     988    123,379    (33,825)   90,542 

 

     Share
capital
  Share
premium
  Accumulated losses  Total
in CHF thousands     
Balance as of January 1, 2017     1,135    188,166    (46,921)   142,380 
Net loss for the period     -    -    (21,782)   (21,782)
Other comprehensive loss     -    -    -    - 
Total comprehensive loss     -    -    (21,782)   (21,782)
                       
Share-based payments     -    -    254    254 
Issuance of shares:                      
restricted share awards     -    8    (8)   - 
exercise of options     7    33    -    40 
Balance as of June 30, 2017     1,142    188,207    (68,457)   120,892 

 

The accompanying notes form an integral part of these Interim Condensed Financial Statements (Unaudited).

 

 4


© AC Immune 2015